Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
URSOPAF: UDCA in FAP Duodenal Adenomas
NCT00134758Phase 3Unknown
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Oct 2004
- Primary completion
- Jun 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of ursodeoxycholic acid in familial adenomatous polyposis (FAP), sponsored by Assistance publique - Hôpitaux de Paris. Status: unknown.
02
Drugs
ursodeoxycholic acid
03
Conditions
familial adenomatous polyposis (FAP)
Beyond the preview
Go deeper on NCT00134758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00134758.